Global Assets Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Global Assets Advisory's BMY Position: Q2 2026 in Review
Global Assets Advisory sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 628 shares — an estimated $38.1K sold.
Global Assets Advisory first reported a position in BMY in Q3 2022 and held it in 4 quarters. The position peaked at $227K in Q4 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Global Assets Advisory reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Global Assets Advisory sold 628 Bristol-Myers Squibb shares in Q2 2026, an estimated $38.1K.
- Global Assets Advisory first reported a position in Bristol-Myers Squibb in Q3 2022 and held it in 4 quarters.
- Global Assets Advisory's Bristol-Myers Squibb position peaked at $227K in Q4 2022.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Global Assets Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.